#1-Smiley Riley(#698510 -From your link (thank you
Post# of 148181
(Total Views: 719)
Posted On: 12/27/2020 11:01:51 PM
Re: SmileyRiley #69851
#1-Smiley Riley(#698510 -From your link (thank you)
" Of course there is a pecking order, and Big Pharma companies all got their first shots BUT now, its anyone and everyone on deck, so if we have to let a small burgeoning Biotech grab the Golden Apple, then so be it. I cannot WAIT for the movie! Or 60 Minutes , which ever comes first.
"This drug fought for many years an incredible uphill battle for HIV against big money of BP. Politicans, doctor- beaucrats and elite have never given this little company any support. Many ten- thousand people died because available medication was not made available to people."
"Great point John! "no longhauler illness." Your 80% reference demands OWS funding. $1 towards Leronlimab = 80% save rate. $1 towards a vaccine, a probable save (what percentage get vaccinated, yet never would have gotten the illness). I put OWS funding for LL at $480M (minimum). Take care, Dave"
"Thankfully Nader had the foresight to pre-qualify Lonza’s large bioreactor facilities in Europe and to have the seed stock already prepared"
"Clearly this means FDA approval is imminent, and this will ultimately be of great benefit with the potential to cut Covid deaths by at least 80% with no “longhauler” illness because this MAB is designed to modulate and fortify the body’s own immune system to defeat the infection quickly in even the sickest patients."
" Of course there is a pecking order, and Big Pharma companies all got their first shots BUT now, its anyone and everyone on deck, so if we have to let a small burgeoning Biotech grab the Golden Apple, then so be it. I cannot WAIT for the movie! Or 60 Minutes , which ever comes first.
"This drug fought for many years an incredible uphill battle for HIV against big money of BP. Politicans, doctor- beaucrats and elite have never given this little company any support. Many ten- thousand people died because available medication was not made available to people."
"Great point John! "no longhauler illness." Your 80% reference demands OWS funding. $1 towards Leronlimab = 80% save rate. $1 towards a vaccine, a probable save (what percentage get vaccinated, yet never would have gotten the illness). I put OWS funding for LL at $480M (minimum). Take care, Dave"
"Thankfully Nader had the foresight to pre-qualify Lonza’s large bioreactor facilities in Europe and to have the seed stock already prepared"
"Clearly this means FDA approval is imminent, and this will ultimately be of great benefit with the potential to cut Covid deaths by at least 80% with no “longhauler” illness because this MAB is designed to modulate and fortify the body’s own immune system to defeat the infection quickly in even the sickest patients."
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼